Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors

Oncotarget. 2017 Feb 28;8(9):16099. doi: 10.18632/oncotarget.15755.
No abstract available

Publication types

  • Published Erratum